Visit marketresearcmoz at Ping.sg
Home » Posts filed under Research in china
Showing posts with label Research in china. Show all posts
Showing posts with label Research in china. Show all posts

Trends of Isostatic Graphite Market in China & Global Regions

Posted by Unknown Tuesday, 3 September 2013 0 comments
MarketResearchMoz.com add new market research report "Global and China Isostatic
Graphite Industry Report, 2013-2015(http://www.marketresearchmoz.com/market-research/global-and-china-isostatic-graphite-173837)" to its store. Isostatic graphite as a kind of high-tech core basic raw material has a wide range of applications in photovoltaic, electrical discharge machining, optical fiber manufacturing, new nuclear power and other fields. After 2006, the rapid rise of the global PV industry quickly broke the original isostatic graphite market supply and demand balance, the market supply has been increasingly tight. 

In this context, isostatic graphite manufacturing giants in the United States, Japan, Europe and other places have invested heavily in succession to expand production capacity significantly, so as to ease the strained market supply somewhat. In 2012, the global isostatic graphite market supply gap was merely 1,000 tons. During the current round of isostatic graphite capacity expansion, China has become a popular investment area and the most important consumer market.

As the world’s manufacturing powerhouse and the largest producer of photovoltaic products, China has maintained a huge amount of demand for isostatic graphite. In recent years, with the swift and violent development of the domestic photovoltaic industry, the demand has shown a trend of year-by-year expansion. During the corresponding period, due to the weak technological base of local isostatic graphite manufacturers coupled with technical blockade of foreign enterprises, China’s isostatic graphite production and quality have not been effectively improved.

In 2012, despite a crisis encountered by the photovoltaic industry, China still held demand of 22,000 tons for isostatic graphite, while isostatic graphite production over the same period was only 16,500 tons, with supply gap up to 5,500 tons. For Chinese enterprises newly involved in the isostatic graphite business, there is currently a widespread lack of technical reserves, unreasonable product structure and other issues, which are difficult to be solved shortly. Therefore, it is expected that China’s large-size, fine-structure, high-end isostatic graphite product market supply over the next few years will still remain tight.
Foreign isostatic graphite production is mainly concentrated in three enterprises, i.e. Japan-based Toyo Tanso Co., Ltd., France-based Mersen Group and Germany-based SGL Group, all with production bases in China.

Toyo Tanso as the world’s largest isostatic graphite enterprise reached isostatic graphite produciton capacity of 11,000 tons/year in 2012, with products covering the main downstream areas. For now, the company’s 4,000-ton isostatic graphite production line is still under construction, once put into production, the total isostatic graphite production capacity will amount to 15,000 tons / year.

Mersen (Ex LCL) is the world’s first isostatic graphite production enterprise that sets up production base in China. In 2012, the completion of the Chongqing base capacity expansion project made its isostatic graphite capacity up to 12,000 tons/year.

After the acuquisition of Chengdu Carbon Co., Ltd., Fangda Carbon New Material Co., Ltd. became the only local owner of mature isostatic graphite production technology. In 2012, the company’s isostatic graphite capacity achieved 4,000 tons/year. Currently, its 30,000 tons/a special graphite project has been approved by the general meeting of stockholders, the forward isostatic graphite production capacity is expected to hit 24,000 tons/year.

Global and China Chlor-alkali Industry Report, 2013

Posted by Unknown Monday, 26 August 2013 0 comments
The industry producing chemicals with sodium hydroxide (caustic soda), chlorine and hydrogen made
through the electrolysis of crude salt solution is known as the chlor-alkali industry, involving more than 200 product varieties including caustic soda (NaOH), polyvinyl chloride (PVC), hydrochloric acid, liquid chlorine, hydrogen, methane chloride and epichlorohydrin, among which, caustic soda and PVC are the most important ones.


In 2012, China’s caustic soda production capacity was 37.36 million tons (up 9.5% year on year), the output was 26.99 million tons (up 9.42% year on year), and the capacity utilization was 72.2%. Caustic soda enterprises are mainly concentrated in North China, East China and Northwest China. In 2012, the top five provinces by output were Shandong, Jiangsu, Henan, Inner Mongolia and Zhejiang, accounting for 21.69%, 15.36%, 6.24%, 6.06% and 5.20% of total caustic soda output respectively.

Since mid-August 2010, China’s increasing power limitation, production restriction, energy conservation and emission reduction policies, high crude salt prices and stable downstream demand have directly promoted the prices of caustic soda. In July-August 2012, the price of caustic soda was up to RMB 960 / ton, an increase of RMB 260 / ton compared with RMB 700 / ton in January-March 2011. 

In 2012, China’s PVC production capacity was 23.41 million tons (an increase of 8.23% year on year, accounting for 44.4% of the global total), and the output was 13.18 million tons (up 1.74% year on year). China’s PVC capacity utilization declined from 71.1% to 51.4% in 2006-2009, and then picked up in 2010-2011, but declined by 3.6 percentage points year on year to 56.3% in 2012, and remained below 70% in the year, with an evident trend of overcapacity.

An overview of the chlor-alkali industry(http://www.marketresearchmoz.com/market-research/global-and-china-chlor-alkali-172816) shows that the production center is obviously transferring towards the central and western regions, and the capacity of enterprises in the central and eastern regions without resource advantages will gradually shrink. In the future, in the resource-rich western region, large conglomerates with raw material, cost, technology, capital and management advantages as well as integrated industrial chains will hold advantageous and controlling positions in the competition.

Global and China Chlor-alkali Industry Report, 2013 of ResearchInChina analyzes the global and Chinese chlor-alkali industry and market, introduces the market conditions of main chlor-alkali products (caustic soda, PVC), and other chlor-alkali products (liquid chlorine, hydrochloric acid, methane chloride, propylene oxide, TDI, MDI). The main contents include:

Development overview of global chlor-alkali industry (including caustic soda and PVC capacity, output, import and export volume, apparent consumption by country);
Development overview of Chinese chlor-alkali industry (including development status, industry characteristics, industry authorities, relevant policies, development bottleneck, development trends);
Development overview of Chinese caustic soda and PVC industries (including production capacity, output, import and export, apparent consumption, price trends, regional markets, competition pattern);
Upstream and downstream product markets of caustic soda and PVC in China (including upstream products such as electricity, crude salt, calcium carbide, ethylene, and downstream industries like alumina, paper pulp, chemical fiber, plastic products);
The operation, revenue structure, gross margin, output and sales volume of chlor-alkali products, cost structure, top five customers, and competitive advantages of ten major companies in Chinese chlor-alkali industry.

China Human Vaccine Industry Report, 2012-2015 Available on MarketResearchMoz.com

Posted by Unknown 0 comments
In the wake of China's economic growth and enhanced disease prevention awareness, Chinese
human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5 billion with the lot release quantity of roughly 773 million person-portions. Restricted by China's national conditions and policies, EPI vaccines still prevail in China and Chinese EPI vaccine market is almost monopolized by state-run enterprises represented by CNBG Tiantan Biological, Biological Products Institutes in Changchun, Chengdu, Wuhan, Shanghai and Lanzhou, and Institute of Medical Biology of Chinese Academy of Medical Sciences in Kunming. In 2012, state-owned enterprises seized 81.5% of the vaccine lot release quantity in Chinese EPI vaccine market.


However, along with the gradual relaxed access to the vaccine market, private companies have sprung up in the Extra EPI vaccine market and acquired more market share. Meanwhile, foreign counterparts occupy considerable market share by virtue of their technological and product advantages. In 2012, private and foreign-funded enterprises occupied 49.9% and 22.1% (by lot release quantity) of Chinese Extra EPI vaccine market respectively. As for human rabies vaccine and varicella vaccine markets, they mastered more than 85% of each.

In recent years, China has made some achievements in overseas vaccine markets. In 2011-2012, China’s annual human vaccine export volume remained over 9,000 tons (9,840 tons in 2010 was subject to the accidental H1N1 flu event), far more than 8,110 tons in 2009. Moreover, many domestic vaccine companies are still planning overseas markets aggressively.

By the end of 2012, the first batch of Hib vaccine products of Walvax Biotechnology were approved by China Customs and exported to Manila, Philippines for official marketing. Walvax Biotechnology is promoting the product registration in Russia, India, Thailand and other countries. In November 2012, Hualan Biological Engineering mailed three consecutive batches of samples for influenza virus split vaccine to WHO for testing. The company is expected to receive WHO’s spot verification certification in 2013. On March 7, 2013, Tiantan Biological obtained the production approval for polio attenuated live vaccine (liquid OPV). In accordance with the cooperation agreement with Bill & Melinda Gates Foundation in 2011, Tiantan Biological will supply OPV to United Nations International Children’s Emergency Fund (UNICEF) formally.

In addition, it is worth mentioning that the industrialization of the world's first recombinant hepatitis E vaccine (Escherichia coli) developed by Xiamen University and YangShengTang INNOVAX jointly was realized on October 27, 2012. As of the end of 2012, the lot release quantity of the product hit 90,000 person-portions.

China Human Vaccine Industry Report, 2012-2015 mainly contains the following aspects:
Operating environment, status quo, market supply and demand, competition pattern and development prospects of human vaccine in China;
Market supply and demand, competition patterns, market prices and development trends of 10 kinds of products including hepatitis B vaccine, influenza vaccine, Hib vaccine, human rabies vaccine and pneumococcal vaccine in China;
Import & export volume and value as well as import sources & export destinations of human vaccine in China;
20120114.gif?Operation, revenue structure, vaccine business and development trends of 11 Chinese vaccine enterprises including Tiantan Biological, Hualan Biological Engineering, Zhifei Biological, Walvax Biotechnology and Sinovac Biotech.






Copyright © 2013 Market Research Moz. All rights reserved.

created by Market Research Reports